102 filings
10-Q
2024 Q2
CNTA
Centessa Pharmaceuticals plc
Quarterly report
13 Aug 24
7:27am
8-K
CNTA
Centessa Pharmaceuticals plc
13 Aug 24
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for Anticipated Upcoming Program Milestones
7:15am
8-K
CNTA
Centessa Pharmaceuticals plc
25 Jun 24
Submission of Matters to a Vote of Security Holders
4:14pm
8-K
CNTA
Centessa Pharmaceuticals plc
10 Jun 24
Departure of Directors or Certain Officers
7:13am
DEFA14A
CNTA
Centessa Pharmaceuticals plc
20 May 24
Additional proxy soliciting materials
8:48pm
8-K
wfex ecj4g7z
13 May 24
Centessa Pharmaceuticals Reports Financial Results and Business Highlights for Anticipated Upcoming Program Milestones
4:23pm
ARS
dr77mvu 3vu3
9 May 24
Annual report to shareholders
8:01am
PRE 14A
2vikt
26 Apr 24
Preliminary proxy
4:36pm
424B5
9ec7n em2
24 Apr 24
Prospectus supplement for primary offering
8:53pm
8-K
8ep58yv3 lc8
24 Apr 24
Centessa Pharmaceuticals Announces $100 Million Proposed Public Offering of American Depositary Shares
9:26am
424B5
yh11074vcoo
23 Apr 24
Prospectus supplement for primary offering
5:16pm
8-K
8ujcxk9bq hs7jldu1
22 Apr 24
Regulation FD Disclosure
7:15am
S-8
6hlr726qexev7
28 Mar 24
Registration of securities for employees
5:01pm
8-K
fafzn 827isq
28 Mar 24
Centessa Pharmaceuticals Reports Business Highlights and Financial Results for the Fourth Quarter and Full-Year 2023
4:35pm
8-K
j0gc11 tuco
9 Feb 24
Regulation FD Disclosure
7:12am
8-K
ks95jn
9 Jan 24
Regulation FD Disclosure
7:56am
8-K
s1wmq91omn68x
11 Dec 23
Regulation FD Disclosure
7:05am